CIK 0001404281 · Non-accelerated filer<br>Smaller reporting company
Eledon Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ELDN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 949-238-8090
- Business address
- 19800 MACARTHUR BLVD., SUITE 250, IRVINE, CA, 92612
- Former names
- Eledon Pharmaceuticals, Inc., Novus Therapeutics, Inc., Tokai Pharmaceuticals Inc
- 8-K Event Other events
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Results of operations
- 10-K Report Annual Report
- 4 Grant or award President acquired 20,000 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 25,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 8-K Event Regulation FD disclosure
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 4 Open-market buy President bought 33,680 shares at an average $4.78 ($161,147)
- 4 Open-market buy President bought 805 shares at $3.97 ($3,193)
- RW Other RW
- S-1/A Offering Registration Statement
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- S-1 Offering Registration Statement
- EFFECT Other Notice of Effectiveness
- UPLOAD Other SEC-generated Letter
- CORRESP Other Correspondence Between Filers and SEC Staff
Page 19 of 31 · 616 filings